2 results
Approved WMOCompleted
To confirm the safety of the Articulinx ICC by evaluating device- and procedure relates adverse events.
Approved WMOCompleted
Explore efficacy, safety, and feasibility (of an eventual future phase 3 trial) of intravenous immunoglobulins as treatment for patients with idiopathic inflammatory myopathies.